Navigation Links
Biology Technology
| 5/22/2013 | Boston, MA (PRWEB) May 22, 2013 Industry leaders from around the world will convene in Alexandria, VA for the Oak Ridge National Laboratory’s Biosurveillance Symposium on June 17th which will take place at the Hilton Alexandria Mark Center. Held in conjunction will be the Biodetection Technologies 2013 conference on June 18 - 19. Join the Many Organizations Already Participating:... [Comments] |
iLuv Now Shipping the All New MultiCharger-X
| 5/22/2013 | Port Washington, NY (PRWEB) May 22, 2013 iLuv Creative Technology, the premier provider of the most comprehensive line of accessories for the mobile lifestyle, announces they are now shipping MultiCharger-X, an easy way to charge, sync, protect, and manage multiple iPad devices efficiently. Winner of the 2013 internationally recognized iF product design award and the 2012 Good Design award,... [Comments] |
Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill
| 5/22/2013 | Boston, MA (PRWEB) May 22, 2013 Cambridge Semantics was one of just 22 companies invited to present at last week’s “Data Demonstration Day” on Capitol Hill, hosted by The Data Transparency Coalition. Cambridge Semantics joined EMC, Google, Microsoft and others to showcase how innovative data management applications can address the requirements of the proposed Digital Accountability and... [Comments] |
Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
| 5/22/2013 | New York (PRWEB) May 22, 2013 The Conference Forum announced the launch of the 3rd Annual Disruptive Innovations to Advance Clinical Trials conference taking place on September 19-20 at the Fairmont Copley Plaza Hotel in Boston, MA. Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, Genzyme, Janssen Pharmaceuticals and more share bold approaches to reduce expensiv... [Comments] |
Oligomerix, Inc. Completes Series B Financing
| 5/22/2013 | NEW YORK , May 22, 2013 Oligomerix, Inc. , a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today the completion of its Series B financing, which includes both issuance of new convertible preferred shares and warrants that would represent approximately $2.... [Comments] |
| 5/22/2013 | BUFFALO, N.Y. , May 22, 2013 Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that could help in diagnosing and determining treatment for patients with neuroendocrine (NEPC) prostate cancer. Neuroendocrine prostate cancer (NEP... [Comments] |
Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
| 5/22/2013 | SEABROOK, N.H. , May 22, 2013 Superior Controls, Inc. has been named "Manufacturing/Technology Business of the Year 2013" by Business NH Magazine. For the past 22 years, the magazine has recognized Granite State organizations that distinguish themselves with extraordinary business and civic excellence. "We are very proud to receive this honor," said Rick Pierro... [Comments] |
| 5/22/2013 | CANTON, Mass. and NEW ORLEANS , May 22, 2013 Organogenesis Inc., a commercial leader in the field of regenerative medicine, presented new data generated in collaboration with a team of expert economists from Analysis Group (a leading health economics consultancy) demonstrating the significant healthcare resource and economic burden that diabetic foot ulcers (DFU) and... [Comments] |
AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
| 5/22/2013 | Basel, Switzerland (PRWEB) May 22, 2013 Genedata, a leading provider of advanced software solutions for industrial biotechnology, drug discovery, and life science research, today announced AB Enzymes will use Genedata Selector ™ as its bioinformatics platform for strain genome data management on all its production-relevant organisms. Genedata will provide AB Enzymes, one of the world’s ol... [Comments] |
Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference
| 5/22/2013 | BUFFALO, N.Y. , May 22, 2013 Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Second Annual Marcum LLP Microcap Conference, May 30, in New York, NY . Neil Lyons , CPA, Chief Financial Officer of Cleveland BioLabs, will present the Company's oncology and biodefense programs on May 30 at 1:30 p.m. Eastern Time.&... [Comments] |
AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing
| 5/22/2013 | Toronto, Ontario (PRWEB) May 22, 2013 AudioNotch is the leading provider of advanced sound therapy for tinnitus treatment. AudioNotch is pleased to announce a partnership with Destination Hearing . With clinic locations in both British Columbia and Alberta, Destination Hearing is a trusted provider of audiology and hearing services. AudioNotch's tinnitus treatment program is now avai... [Comments] |
Medicine Technology
| 5/22/2013 | WHITE PLAINS, N.Y. , May 22, 2013 The Leukemia & Lymphoma Society (LLS) is committing approximately $6 million to Valor Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, to co-fund the completion of pre-clinical development, manufacturing, and a Phase I clinical trial for a novel fusion protein that may change the poor outcomes faced by many patie... [Comments] |
| 5/22/2013 | WILMINGTON, Del. and MUNICH , May 22, 2013 JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today its first interim results of the J enaValve Eval U ation of Long Term P erformance and Safety I n Pa T ients with... [Comments] |
| 5/22/2013 | PARIS and CAESAREA, Israel , May 22, 2013 New clinical data presented from the DEFLECT-I study demonstrates that Keystone Heart's TriGuard ™ Cerebral Protection Device reduces brain lesion volume during TAVR (Transcatheter Aortic Valve Replacement) procedures when compared to historical data. Keystone Heart Scientific Advisory Board announces consensu... [Comments] |
| 5/22/2013 | NEW YORK , May 22, 2013 The Lupus Research Institute (LRI) today is hosting the first international conference devoted to advancing new treatments for lupus nephritis, a serious kidney complication of lupus affecting up to 60 percent of patients. The conference launched a new international alliance of researchers specializing in lupus nephritis – the Lupus Nephritis... [Comments] |
Is There Finally A Way To Stop Severe Excessive Sweating?
| 5/22/2013 | NEW YORK , May 22, 2013 For the 3% of the population that suffer from hyperhidrosis, their severely excessive sweating is often embarrassing, uncomfortable, anxiety-inducing and disabling. While more than half of these people are never diagnosed or treated for their symptoms, hyperhidrosis is a serious medical condition. Finally, there is a one-time, perm... [Comments] |
| 5/22/2013 | PASADENA, Calif. , May 22, 2013 The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published today in Vaccine. The U.S. Food and Drug Administration approved PCV13 for use beginning in 2010 after a series of trials... [Comments] |
| 5/22/2013 | SEATTLE , May 22, 2013 Milliman, Inc., a premier global consulting and actuarial firm, today released the results of its 2013 Milliman Medical Index (MMI), which measures the healthcare costs for a typical American family of four receiving healthcare benefits through an employer-sponsored preferred provider organization (PPO) plan. The cost of care for this typical family... [Comments] |
| 5/22/2013 | CLEVELAND , May 22, 2013 Healthcare providers are turning to OnBase, Hyland Software's enterprise content management (ECM) solution, for a deeper integration with Meditech's Hospital Information System . These organizations identified enterprise content management as a core IT system and will use OnBase to optimize their Meditech system and address strategic corp... [Comments] |
Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry
| 5/22/2013 | LEWIS CENTER, Ohio , May 22, 2013 Modern Medical announced today the nationwide rollout of Opioid Defense Manager™ (ODM). Launched in November 2012 in a test phase, ODM is Modern Medical's revolutionary managed care program to stop the rising opioid abuse in the workers' compensation industry. ODM is a proactive, customized program designed to protect em... [Comments] |
Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer
| 5/22/2013 | PRINCETON, New Jersey , 22. Mai 2013 Kepner-Tregoe (KT), das globale Unternehmen für Fähigkeitsentwicklung und Beratung, gab heute bekannt, dass der Veteran von 13 Jahren, Chris Geraghty , zum Hauptgeschäftsführer ernannt wurde. Geraghty's Erfahrung umfasst mehr als 20 Jahre im Industriebereich wo er zahlreiche Führungspositionen bei Fertigungsunter... [Comments] |
| 5/22/2013 | NEW YORK , May 22, 2013 Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Intuitive Surgical, Inc. ("Intuitive Surgical" or the "Company") (NASDAQ: ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical common stock between October 19, 2011 and April 18, 2013 (the "Class Period"). Such investors are advised to cont... [Comments] |
(Date:5/22/2013)... York (PRWEB) May 22, 2013 ... 3rd Annual Disruptive Innovations to Advance Clinical Trials conference ... Plaza Hotel in Boston, MA. , Disruptive thinkers ... Pharmaceuticals and more share bold approaches to reduce expensive ... , “Disruptive innovation needs to be big, or novel, ...
(Date:5/22/2013)... ORLEANS , May 22, 2013 Organogenesis Inc., ... presented new data generated in collaboration with a team ... economics consultancy) demonstrating the significant healthcare resource and economic ... ulcers (VLU) place upon the US healthcare system. ... annual costs of up to $15 billion and $18 ...
(Date:5/22/2013)... Mold remediation could take a toll on one's pocket. ... to cut down the process' expense. And so, to help ... of a method how to kill mold effectively ... My Cleaning Products said. But in case mold gets past ... must then be promptly implemented as it poses several health ...
(Date:5/22/2013)... 22, 2013 A recent study from ... athletes to find that those who took probiotics were able ... from the study showed that in extreme heat conditions, probiotics ... their adult acne treatment explains what this new ... may help their skin condition. , While researchers tote ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2[0] Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches[0] Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers[0] How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products[0] Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers
... Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer ... bioimplants processed from human amniotic membrane, announced today ... Systagenix, whereby Systagenix will co-market EpiFix®. The MiMedx ... amniotic tissue, EpiFix® offers a wide variety of ...
... first Minority Biomedical Entrepreneurship Conference (MBEC), will convene ... platform for minority professionals, entrepreneurs, investors, students and ... ideas. (Logo: http://photos.prnewswire.com/prnh/20120319/DC71722LOGO ) ... of the growing biomedical industry workforce, and a ...
... DIEGO and PHILADELPHIA, March 19, 2012 Toby Odenheim, director ... contract research organization (CRO), is slated to present on ... at the Outsourcing in Clinical Trials, East Coast ... Odenheim will speak at 11 a.m. EDT, Wed., March 28, ...
Cached Biology Technology:MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix® 2MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix® 3Minority Biomedical Entrepreneurship Conference 2Minority Biomedical Entrepreneurship Conference 3Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference 2Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference 3(Date:5/22/2013)... TORONTO , May 22, 2013 /PRNewswire/ ... announced three presentations demonstrating the superiority of the AE37 ... Antigen Express, Inc. ( www.antigenexpress.com ). The presentations will ... Society of Clinical Oncology (ASCO) to be held in ... June 4, 2013. The presentation entitled " ...
(Date:5/22/2013)... -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary ... announced on May 22 the actions that Ranbaxy ... conduct under prior management ( ... to support Ranbaxy in its efforts to address ... led to the investigations by the U.S. Department ...
(Date:5/22/2013)... 22. Mai 2013 Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4[0] Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine[0] Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives[0] Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
... Based on its recent analysis of the ... Visage Imaging, Inc. with the 2010 North American ... Award. (Logo: http://photos.prnewswire.com/prnh/20081117/FSLOGO ) ... 2009, Visage Imaging has operated as a wholly ...
... PLEASANTON, Calif., Oct. 25 Roche (SIX: RO, ... Food & Drug Administration (FDA) has approved the ... research organizations have depended on COBAS® TaqMan® technology ... This new test will help clinicians to more ...
Cached Medicine Technology:Frost & Sullivan Recognizes Visage Imaging, Inc. for its Medical Imaging Informatics in Healthcare Innovation 2Frost & Sullivan Recognizes Visage Imaging, Inc. for its Medical Imaging Informatics in Healthcare Innovation 3Frost & Sullivan Recognizes Visage Imaging, Inc. for its Medical Imaging Informatics in Healthcare Innovation 4Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test 2Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test 3| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |